Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. A Venous Stent is a self-expandable metallic stent with a perforated tube which is inserted into a vein to prevent blood flow constriction caused by obstructions and occlusions in the venous vasculature. GlobalData uses proprietary data and analytics to provide a comprehensive report on the venous stents devices market, including market shares of different players within South Korea. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the venous stents market in South Korea was Medtronic followed by CR Bard and Becton Dickinson and Co.
Venous Stent placement is considered in case of significant stenosis or extrinsic compression. Venous Stents placed in the iliofemoral vein are covered.
The value of the venous stents devices market within South Korea was expected to be over $8m in 2023.
For the latest complete market share analysis of venous stents device market in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
